<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03207633</url>
  </required_header>
  <id_info>
    <org_study_id>Low frequency TMS in OCD</org_study_id>
    <nct_id>NCT03207633</nct_id>
  </id_info>
  <brief_title>Low Frequency TMS on DLPFC and OFC in OCD Patients</brief_title>
  <official_title>Comparative Study of the Therapeutic Effect of Low Frequency TMS on DLPFC and OFC in OCD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the therapeutic effect of low frequency rTMS over the right&#xD;
      DLPFC, versus right OFC versus Sham group of obsessive-compulsive disorder (OCD) patients.&#xD;
      Sixty patients will be recruited from the out-patient psychiatric clinic of a university&#xD;
      hospital, and randomized into three equal groups. The 1st group will receive 10 sessions of&#xD;
      low frequency rTMS targeting right DLPFC by means of a butterfly coil, 120% RMT, 1 Hz, 3&#xD;
      trains, each of 500 pulses with a 40 seconds inter-train interval allowing the coil to cool.&#xD;
      The 2nd group will receive 10 sessions of low-frequency rTMS over the right orbitofrontal&#xD;
      cortex (OFC), the international 10-20 EEG system will be used to position the coil over the&#xD;
      right OFC, at the right frontopolar 2 (Fp2) electrode site, using the following parameters:&#xD;
      120% motor threshold, 1 Hz, 3 trains, each of 500 pulses with a 40 seconds inter-train&#xD;
      interval allowing the coil to cool. The 3rd group will receive sham stimulations with the&#xD;
      same pulse delivery as the other groups but with the coil placed perpendicular to the scalp.&#xD;
&#xD;
      The resting motor threshold (RMT) and cortical silent period (CSP) at different intensities&#xD;
      from 110 % to 150 % will be measured before and after the end of sessions. All assessments&#xD;
      like (Y-BOCS), (HAM-A), Beck Depression Inventory, (CGI-S), (MoCA) will be performed before&#xD;
      and after end of the sessions and 3 months later.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to evaluate the therapeutic effect of low frequency rTMS over the right&#xD;
      DLPFC, versus right OFC versus Sham group of OCD patients. Sixty patients will be recruited&#xD;
      from the out-patient psychiatric clinic of a university hospital, the patients will be&#xD;
      randomized into three groups (20 patients for each group) using closed envelopes.&#xD;
&#xD;
      The first group (20 patients) will receive 10 sessions of low frequency rTMS targeting right&#xD;
      DLPFC by means of a Butterfly coil, The DLPFC stimulation site was defined as the region 5 cm&#xD;
      dorsolateral in the same sagittal plane as the optimal site for MT production in the first&#xD;
      dorsal interosseous, using the following parameters: 120% RMT, 1 Hz, 3 trains, each of 500&#xD;
      pulses with a 40 seconds inter-train interval allowing the coil to cool.&#xD;
&#xD;
      The second group (20 patients) will receive 10 sessions of low-frequency rTMS over the right&#xD;
      orbitofrontal cortex (OFC) by means of a butterfly coil, the international 10-20 EEG system&#xD;
      will be used to position the coil over the right OFC, at the right frontopolar 2 (Fp2)&#xD;
      electrode site, using the following parameters: 120% motor threshold, 1 Hz, 3 trains, each of&#xD;
      500 pulses with a 40 seconds inter-train interval allowing the coil to cool.&#xD;
&#xD;
      The third group (the sham condition) (20 patients) group will receive sham stimulations with&#xD;
      the same pulse delivery as the other groups but with the coil placed perpendicular to the&#xD;
      scalp.&#xD;
&#xD;
      The resting motor threshold (RMT) and cortical silent period (CSP) at different intensities&#xD;
      from 110 % to 150 % will be measured before and after the end of sessions. All assessments&#xD;
      like (Y-BOCS), (HAM-A), Beck Depression Inventory, (CGI-S), (MoCA) will be performed before&#xD;
      and after end of the sessions and 3 months later.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Actual">July 30, 2018</completion_date>
  <primary_completion_date type="Actual">July 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Yale-Brown Obsessive Compulsive Scale (Y-BOCS)</measure>
    <time_frame>Three months</time_frame>
    <description>Assessment of Obsessive Compulsive disorder using (Y-BOCS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hamilton Anxiety Rating Scale (HAM-A)</measure>
    <time_frame>Three months</time_frame>
    <description>Assessment of anxiety using Hamilton scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Beck Depression Inventory</measure>
    <time_frame>Three months</time_frame>
    <description>Assessment of Depression using Beck depression inventory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Global Impression-Severity scale (CGI-S)</measure>
    <time_frame>Three months</time_frame>
    <description>Assessment of clinical severity using CGI-S</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montreal Cognitive Assessment (MoCA)</measure>
    <time_frame>Three months</time_frame>
    <description>Assessment of cognitive function using (MoCA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of cortical excitability parameters (RMT and CSP)</measure>
    <time_frame>Ten days</time_frame>
    <description>Measurment of changes of cortical excitability parameters (RMT and CSP) before and after sessions in the three groups.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Psychiatric Disorder</condition>
  <arm_group>
    <arm_group_label>First group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>First group (20 patients) receive for 10 sessions of low frequency rTMS targeting right DLPFC by means of a Butterfly coil using the following parameters: 120% RMT, 1 Hz, 3 trains, each of 500 pulses with a 40 seconds inter-train interval allowing the coil to cool.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Second group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The second group (20 patients) will receive 10 sessions of low-frequency rTMS over the right orbitofrontal cortex (OFC) by means of a Butterfly coil using the following parameters: 120% motor threshold, 1 Hz, 3 trains, each of 500 pulses with a 40 seconds inter-train interval allowing the coil to cool.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Third group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The third group (the sham condition) (20 patients) will receive sham stimulations of rTMS with the same pulse delivery as the other groups but with the coil placed perpendicular to the scalp.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Repetitive trans-magnetic stimulation (rTMS) on DLPFC</intervention_name>
    <description>Repetitive trans-magnetic stimulation (rTMS) on DLPFC</description>
    <arm_group_label>First group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Repetitive trans-magnetic stimulation (rTMS) on OFC</intervention_name>
    <description>Repetitive trans-magnetic stimulation (rTMS) on OFC</description>
    <arm_group_label>Second group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham repetitive trans-magnetic stimulation (rTMS)</intervention_name>
    <description>Sham repetitive trans-magnetic stimulation (rTMS)</description>
    <arm_group_label>Third group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  being 18 or over&#xD;
&#xD;
          -  being assigned a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition&#xD;
             (DSM-IV) or DSM-V diagnosis of OCD by the referring psychiatrist&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  (1) presenting established cognitive or communication problems which makes it&#xD;
             challenging to understand the questionnaires and take part in the therapeutic&#xD;
             encounters&#xD;
&#xD;
          -  (2) suffering from other severe psychiatric disorders, metabolic, or neurological&#xD;
             disorders .&#xD;
&#xD;
          -  (3) Patients with pacemaker, or metallic devices&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eman M Khedr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Neurology, Faculty of Medicine, Assiut University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eman Khedr</name>
      <address>
        <city>Assiut</city>
        <zip>11517</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 24, 2017</study_first_submitted>
  <study_first_submitted_qc>July 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2017</study_first_posted>
  <last_update_submitted>September 12, 2020</last_update_submitted>
  <last_update_submitted_qc>September 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Eman M. Khedr</investigator_full_name>
    <investigator_title>Professorf</investigator_title>
  </responsible_party>
  <keyword>OCD, rTMS, right orbitofrontal cortex</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Problem Behavior</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

